Loading
Latest filing published 24 Aug 2026 for Quantum BioPharma Ltd., €51k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Nathan Patrick Coyle in Quantum BioPharma Ltd. In total, 4 filings cover trades dated from 15 August 2024 to 20 August 2026.
On the market, this insider has only sold: 1 sale, €39k in total. Outside the open market, there are 2 option exercises.
The record was last updated on 24 August 2026 with an option exercise (€51k) in Quantum BioPharma Ltd. Between a trade and the moment it shows up on SEDI, the median delay is 11 days. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration